Literature DB >> 3977418

Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.

I J Russell, R A Walsh.   

Abstract

Two young adults with impending gangrene due to persistent Raynaud's vasospasm were studied by sequential intra-arterial (IA) infusion of three vasodilatory drugs while arterial pressure and plethysmographic digital pulse volume were continuously monitored. The results of the IA infusion accurately predicted relief from vasospastic symptoms by oral drugs of the same class. This method may be useful in selecting the most effective vasodilator for patients with severe vasospasm.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977418      PMCID: PMC1001595          DOI: 10.1136/ard.44.3.151

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

Review 1.  Medical intelligence drug therapy.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1976-08-05       Impact factor: 91.245

2.  Pathophysiology of Raynaud's disease.

Authors:  J L Halperin; J D Coffman
Journal:  Arch Intern Med       Date:  1979-01

3.  Vasodilator therapy of pulmonary hypertension in the CRST syndrome.

Authors:  J McWeeney; P Finnegan
Journal:  Ir J Med Sci       Date:  1982-05       Impact factor: 1.568

4.  A maneuver to reverse Raynaud's phenomenon of the fingers.

Authors:  D R McIntyre
Journal:  JAMA       Date:  1978-12-15       Impact factor: 56.272

5.  Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.

Authors:  C D Smith; R J McKendry
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

6.  Oral hydralazine therapy for primary pulmonary hypertension.

Authors:  L J Rubin; R H Peter
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.